Literature DB >> 12051932

Contrasting IgG structures reveal extreme asymmetry and flexibility.

Erica Ollmann Saphire1, Robyn L Stanfield, M D Max Crispin, Paul W H I Parren, Pauline M Rudd, Raymond A Dwek, Dennis R Burton, Ian A Wilson.   

Abstract

The crystal structure of IgG1 b12 represents the first visualization of an intact human IgG with a full-length hinge that has all domains ordered and visible. In comparison to intact murine antibodies and hinge-deletant human antibodies, b12 reveals extreme asymmetry, indicative of the extraordinary interdomain flexibility within an antibody. In addition, the structure provides an illustration of the human IgG1 hinge in its entirety and of asymmetry in the composition of the carbohydrate attached to each C(H)2 domain of the Fc. The two separate hinges assume different conformations in order to accommodate the vastly different placements of the two Fab domains relative to the Fc domain. Interestingly, only one of two possible intra-hinge disulfides is formed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051932     DOI: 10.1016/S0022-2836(02)00244-9

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  87 in total

1.  Following single antibody binding to purple membranes in real time.

Authors:  Ferry Kienberger; Harald Mueller; Vassili Pastushenko; Peter Hinterdorfer
Journal:  EMBO Rep       Date:  2004-05-14       Impact factor: 8.807

2.  Freezing immunoglobulins to see them move.

Authors:  L Bongini; D Fanelli; F Piazza; P De Los Rios; S Sandin; U Skoglund
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-13       Impact factor: 11.205

Review 3.  The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.

Authors:  Sybille Böhm; Inessa Schwab; Anja Lux; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

4.  Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture.

Authors:  James T Heads; Ralph Adams; Lena E D'Hooghe; Matt J T Page; David P Humphreys; Andrew G Popplewell; Alastair D Lawson; Alistair J Henry
Journal:  Protein Sci       Date:  2012-08-09       Impact factor: 6.725

5.  Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged.

Authors:  Katie J Doores; Zara Fulton; Michael Huber; Ian A Wilson; Dennis R Burton
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

6.  Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides.

Authors:  Michael M C Sun; Kevin S Beam; Charles G Cerveny; Kevin J Hamblett; Richard S Blackmore; Michael Y Torgov; Felicia G M Handley; Nathan C Ihle; Peter D Senter; Stephen C Alley
Journal:  Bioconjug Chem       Date:  2005 Sep-Oct       Impact factor: 4.774

7.  Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.

Authors:  Falk Nimmerjahn; Robert M Anthony; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

8.  Resolving cadherin interactions and binding cooperativity at the single-molecule level.

Authors:  Yunxiang Zhang; Sanjeevi Sivasankar; W James Nelson; Steven Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-29       Impact factor: 11.205

9.  2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.

Authors:  Katie J Doores; Michael Huber; Khoa M Le; Sheng-Kai Wang; Colleen Doyle-Cooper; Anthony Cooper; Ralph Pantophlet; Chi-Huey Wong; David Nemazee; Dennis R Burton
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

Review 10.  Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity.

Authors:  Takehisa Kitazawa; Midori Shima
Journal:  Int J Hematol       Date:  2018-10-22       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.